We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$5.93B
AUM Growth
+$411M
Cap. Flow
+$220M
Cap. Flow %
3.71%
Top 10 Hldgs %
18.58%
Holding
2,656
New
107
Increased
1,107
Reduced
377
Closed
19

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.76M
2
AMZN icon
Amazon
AMZN
+$7.95M
3
DOW icon
Dow Inc
DOW
+$5.98M
4
META icon
Meta Platforms (Facebook)
META
+$4.77M
5
AAPL icon
Apple
AAPL
+$4.04M

Sector Composition

Rank Sector Weight
1 Technology 17.87%
2 Financials 14.23%
3 Healthcare 12.93%
4 Industrials 10.33%
5 Consumer Discretionary 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOOR
1401
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$429K 0.01%
8,150
TEVA icon
1402
Teva Pharmaceuticals
TEVA
$42.6B
$429K 0.01%
46,472
+1,900
+4% +$22.9K
CROX icon
1403
Crocs
CROX
$6.36B
$428K 0.01%
21,669
CDNA icon
1404
CareDx
CDNA
$2.45B
$426K 0.01%
11,835
+479
+4% +$15.3K
STBA icon
1405
S&T Bancorp
STBA
$1.82B
$426K 0.01%
11,360
MKL icon
1406
Markel Group
MKL
$22.8B
$425K 0.01%
390
-2
-0.5% -$2.1K
NPO icon
1407
Enpro
NPO
$7.12B
$425K 0.01%
6,656
APAM icon
1408
Artisan Partners
APAM
$2.97B
$425K 0.01%
15,439
PK icon
1409
Park Hotels & Resorts
PK
$2.99B
$424K 0.01%
15,399
-61
-0.4% -$1.83K
GHDX
1410
DELISTED
Genomic Health, Inc.
GHDX
$424K 0.01%
7,287
+526
+8% +$31.2K
HPP
1411
Hudson Pacific Properties
HPP
$777M
$424K 0.01%
1,819
-13
-0.7% -$3.12K
HLIO icon
1412
Helios Technologies
HLIO
$2.66B
$424K 0.01%
9,128
+336
+4% +$15.7K
STAA icon
1413
STAAR Surgical
STAA
$1.26B
$424K 0.01%
14,415
BRSP
1414
BrightSpire Capital
BRSP
$629M
$423K 0.01%
27,317
RAVN
1415
DELISTED
Raven Industries Inc
RAVN
$423K 0.01%
11,783
+432
+4% +$15.8K
ECOL
1416
DELISTED
US Ecology, Inc.
ECOL
$423K 0.01%
7,098
HRTX icon
1417
Heron Therapeutics
HRTX
$63.5M
$422K 0.01%
22,689
+434
+2% +$8.67K
FCF icon
1418
First Commonwealth Financial
FCF
$2.18B
$421K 0.01%
31,259
+1,185
+4% +$15.6K
ROCK icon
1419
Gibraltar Industries
ROCK
$1.46B
$420K 0.01%
10,400
DENN
1420
DELISTED
Denny's
DENN
$419K 0.01%
20,415
GIII icon
1421
G-III Apparel Group
GIII
$1.41B
$418K 0.01%
14,214
OXM icon
1422
Oxford Industries
OXM
$538M
$417K 0.01%
5,495
RRC icon
1423
Range Resources
RRC
$9.39B
$416K 0.01%
59,655
+229
+0.4% +$1.99K
TR icon
1424
Tootsie Roll Industries
TR
$3.02B
$416K 0.01%
13,853
-41
-0.3% -$1.28K
FATE icon
1425
Fate Therapeutics
FATE
$294M
$415K 0.01%
20,423

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2019 Portfolio in Review

As of Q2 2019, Metropolitan Life Insurance Company (MetLife) held 2,656 positions worth $5.93B, up 7.5% from $5.52B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife) deployed $220M of net new capital in Q2 2019, opening 107 new positions and adding to 1,107 existing holdings. Its largest new stake was Dow Inc: 113,293 shares worth $5.59M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $9.22M trimmed.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2019 buy was Dow Inc: 113,293 shares worth $5.59M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q2 2019, an estimated $9.76M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $9.22M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Integrated Device Technology I in Q2 2019, selling an estimated $3.61M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $5.93B portfolio in Q2 2019.
  • Metropolitan Life Insurance Company (MetLife) opened 107 new positions and closed 19 in Q2 2019.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 7.5% quarter-over-quarter to $5.93B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2019, filed 14 Aug 2019.